Pralidoxime Chloride

2021 ◽  
pp. 1332-1332
Keyword(s):  
2016 ◽  
Vol 20 (4) ◽  
pp. 485-492 ◽  
Author(s):  
Nabeel I. Uwaydah ◽  
Stephen L. Hoskins ◽  
Stephen P. Bruttig ◽  
Henry Farrar ◽  
Nick C. Copper ◽  
...  

2014 ◽  
Vol 22 (2) ◽  
pp. 264-270 ◽  
Author(s):  
Subham Banerjee ◽  
Pronobesh Chattopadhyay ◽  
Animesh Ghosh ◽  
Shiv Sankar Bhattacharya ◽  
Amit Kundu ◽  
...  

1987 ◽  
Vol 21 (7-8) ◽  
pp. 590-593 ◽  
Author(s):  
Dennis F. Thompson ◽  
G. Dail Thompson ◽  
Robert B. Greenwood ◽  
Harold L. Trammel

Pralidoxime chloride is a useful agent in the treatment of organophosphate poisoning. Poisindex, a widely used poisoning treatment resource, recommends dosing pralidoxime chloride as an intermittent iv infusion every 8–12 hours, whereas other authors have used continuous iv infusion with good results. Available animal data suggest that a serum concentration of 4 μg/ml may be a minimal level to protect against the toxic effects of organophosphates. Pharmacokinetic simulations, based on parameters obtained from healthy nonpoisoned subjects, show that pralidoxime levels fall rapidly to <4 μg/ml within 1.5–2 hours after a 1-g iv bolus. Continuous iv infusion (0.5 g/h) maintains pralidoxime levels >4 μg/ml throughout the length of infusion. We conclude that continuous iv infusion of pralidoxime chloride may be the preferred method of administration in patients with acute organophosphate poisoning. Clinical trials will be necessary to document the effectiveness of this regimen.


1988 ◽  
Vol 7 (7) ◽  
pp. 1013-1030 ◽  
Author(s):  
C. Gennings ◽  
R. A. Carchman ◽  
W. H. Carter ◽  
E. D. Campbell ◽  
R. M. Boyle ◽  
...  

The therapeutic efficacy of atropine sulfate/pralidoxime chloride (ATR/2-PAM) treatment therapy and physostigmine (PHY) pretreatment therapy was evaluated in soman-challenged guinea pigs. Response surface analysis (RSM) of treatment efficacy indicated that the optimal ATR/2-PAM dose combination varied as a function of both the soman (GD) challenge level and the PHY pretreatment dose. Efficacy was, therefore, evaluated for varying PHY pretreatment doses in combination with the appropriate optimal ATR/2-PAM treatment (as determined by RSM for each soman challenge dose and PHY dose evaluated). The response surfaces depicting the effects (i.e., probability of survival) of ATR/2-PAM combinations at fixed levels of PHY and GD are presented, and confidence regions and point estimates for optimal ATR/2-PAM treatment combination are included. It was estimated that with optimal therapy a protective ratio (PR) of 6 can be observed. Comparisons were made between the use of PHY/ATR/2-PAM as presented here and the use of PYR/ATR/2-PAM, as discussed by Jones et al.(1) Both studies showed a strong positive (r ≥ 0.98) relationship between dose and the PR. However, the estimated slope parameter for PHY was significantly larger ( P < 0.001) than the slope parameter for pyridostigmine (PYR). This difference in slopes may indicate different mechanisms of action for PYR and PHY.


2016 ◽  
Vol 66 (5) ◽  
pp. 464 ◽  
Author(s):  
R.V. Geetha ◽  
Anitha Roy ◽  
S. Senthilkumar ◽  
A.S.B. Bhaskar ◽  
R. Vijayaraghavan

Chemical and biological weapons can be used during conflicts and by terrorists to injure or kill humans and animals. Chemical weapons contain toxic chemicals and biological weapons contain pathogenic organisms. With proper protective equipments and training, the lethal effects of chemical and biological warfare agents can be minimised. First aid kit is available that contain detection, decontamination and medical protection for chemical warfare agents including autoinjectors, for rapid administration and faster absorption of drugs. The autoinjectors are safe and available for life saving drugs like atropine sulphate and pralidoxime chloride (nerve agent poisoning), epinephrine (anaphylaxis), diazepam (seizures) and sumatriptan (migraine). For bio-threat agents doxycycline alone is available as a broad spectrum antibiotic in the first aid kit. Majority of the bacterial agents are gram negative and hence amikacin drug cartridge was developed for the existing autoinjector. The advantage of amikacin is its safety, stability, can be given prophylactically and supplemented with other antibiotics when medical attention arrives. The usability and tolerability of amikacin administered repeatedly through autoinjector was studied using various haematological, biochemical and oxidative stress parameters in animal models. The results are promising and as there is no antibiotic autoinjector available, amikacin autoinjector can be considered for bio-threat agents.


1989 ◽  
Vol 78 (2) ◽  
pp. 132-136 ◽  
Author(s):  
Alan C. Schroeder ◽  
Joseph H. Digiovanni ◽  
Jurgen Von Bredow ◽  
Melvin H. Heiffer

Sign in / Sign up

Export Citation Format

Share Document